Last reviewed · How we verify
AVANZ Phleum pratense
At a glance
| Generic name | AVANZ Phleum pratense |
|---|---|
| Sponsor | ALK-Abelló A/S |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber (PHASE2)
- An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy (PHASE2, PHASE3)
- Avanz Phleum Pratense Maintenance Dose (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |